Vitamin D benefits: proven, plausible, or hyped
Vitamin D is essential. But “essential” does not mean that extra vitamin D prevents every disease.
Supported for deficiency. Not supported as a broad wellness cure-all.
Vitamin D is proven to help prevent and treat deficiency-related bone disease. The evidence does not support routine extra vitamin D for healthy, non-deficient adults to prevent cancer, heart disease, fractures, depression, colds, or aging.
The claim
“Taking vitamin D supplements improves health and prevents disease.”
This claim is too broad. A better question is: which people, taking what dose, for which outcome?
Vitamin D has a real role in calcium absorption and bone mineralisation. Deficiency can cause rickets in children and osteomalacia, which means soft bones, in adults.1 But many online claims go far beyond deficiency treatment.
At a glance
Deficiency, rickets, osteomalacia
Cancer, heart disease, depression
Respiratory infections
Selected high-risk groups
WEH evidence rating
Vitamin D is a nutrient, not a universal treatment. The evidence is strong for correcting deficiency and meeting normal intake needs. It is weak or negative for many broad supplement claims in people who already have enough vitamin D.
What the best evidence says
Press the arrow for more details. Each evidence card expands to show the study result, strengths, limits, and WEH interpretation.
Supported
Vitamin D helps prevent and treat deficiency-related bone disease
Study types: official evidence summary, clinical guideline, human physiology and clinical nutrition evidence
⌄
Vitamin D helps prevent and treat deficiency-related bone disease
Vitamin D helps the body absorb calcium. Low vitamin D over time can lead to rickets in children and osteomalacia in adults.1
The 2024 Endocrine Society guideline also supports empiric vitamin D for children and adolescents aged 1 to 18 years to prevent nutritional rickets.2
Not supported
Cancer and heart protection are not proven
Study type: large randomized controlled trial
⌄
Cancer and heart protection are not proven
The VITAL trial randomly assigned 25,871 US adults to vitamin D3 2,000 IU/day or placebo and followed them for a median of 5.3 years. Vitamin D did not significantly reduce invasive cancer or major cardiovascular events compared with placebo.4
This is one of the strongest kinds of evidence because the trial was large, randomized, and placebo-controlled.
Not supported
Routine fracture and fall prevention claims are weak in community-dwelling adults
Study types: large RCT, systematic evidence review, guideline recommendation
⌄
Routine fracture and fall prevention claims are weak in community-dwelling adults
In a VITAL fracture analysis, vitamin D3 2,000 IU/day did not significantly lower total fractures, non-vertebral fractures, or hip fractures in generally healthy midlife and older adults who were not selected for deficiency, osteoporosis, or low bone mass.5
The USPSTF draft recommendation found moderate certainty that vitamin D, with or without calcium, has no net benefit for primary prevention of fractures or falls in community-dwelling postmenopausal women and men aged 60 years or older.3
Not supported
Depression prevention is not supported by large trial evidence
Study type: randomized controlled trial ancillary study
⌄
Depression prevention is not supported by large trial evidence
VITAL-DEP included 18,353 adults aged 50 or older. Vitamin D3 2,000 IU/day did not prevent depression or clinically relevant depressive symptoms and did not improve mood scores compared with placebo.6
Uncertain
Respiratory infection prevention is mixed, and newer evidence is less positive
Study type: updated systematic review and meta-analysis of RCTs
⌄
Respiratory infection prevention is mixed, and newer evidence is less positive
A 2025 updated meta-analysis added six newer randomized trials to earlier evidence. For vitamin D versus placebo, the pooled result did not reach statistical significance for preventing acute respiratory infections: odds ratio 0.94, 95% confidence interval 0.88 to 1.00, p=0.057, across 40 studies and 61,589 participants.8
The Endocrine Society still suggests empiric vitamin D for children and adolescents aged 1 to 18 years partly because it may reduce respiratory infections.2
Plausible, not proven
Some selected high-risk groups may benefit
Study types: guideline, large RCT, RCT ancillary analysis
⌄
Some selected high-risk groups may benefit
The 2024 Endocrine Society guideline suggests vitamin D above the usual daily intake for children and adolescents, pregnant women, adults older than 75, and adults with high-risk prediabetes. The guideline also says the optimal blood level and benefit-risk balance for disease prevention remain uncertain.2
In the D2d trial, 2,423 adults with high-risk prediabetes received vitamin D3 4,000 IU/day or placebo. Diabetes risk was lower numerically, but the primary result was not statistically significant.7
In a VITAL autoimmune disease analysis, vitamin D3 2,000 IU/day was linked with fewer confirmed autoimmune diseases than placebo: 123 cases versus 155 cases, hazard ratio 0.78, 95% confidence interval 0.61 to 0.99.9
Hype
Anti-aging, detox, weight loss, and “immune boosting” claims are not proven
Study type: indirect or absent human outcome evidence
⌄
Anti-aging, detox, weight loss, and “immune boosting” claims are not proven
Vitamin D affects many biological systems. That does not prove that supplements extend lifespan, reverse aging, detox the body, or boost immunity in a meaningful clinical way.
The strongest human trials do not show broad disease-prevention benefits in mostly vitamin-D-sufficient adults.456
Key studies
The most useful evidence comes from guidelines, systematic reviews, and large randomized controlled trials.
A randomized controlled trial, or RCT, randomly assigns people to treatment or placebo. It is usually better than an observational study for testing whether a supplement caused a health benefit.
| Source | WEH limitations note |
|---|---|
NIH Office of Dietary Supplements1 |
Not a single trial. It summarizes many evidence streams. |
Endocrine Society 2024 guideline2 |
Many recommendations are conditional. Optimal blood thresholds remain uncertain. |
VITAL cancer and cardiovascular trial4 |
Participants were not selected for vitamin D deficiency. |
VITAL fracture analysis5 |
Does not answer whether deficient or institutionalized people benefit. |
USPSTF 2024 draft recommendation3 |
Does not apply to diagnosed osteoporosis, vitamin D deficiency, or malabsorption. |
VITAL-DEP depression trial6 |
Prevention trial, not a treatment trial for severe deficiency-related symptoms. |
D2d diabetes prevention trial7 |
Most participants had adequate vitamin D at baseline. |
Jolliffe 2025 respiratory infection meta-analysis8 |
Possible small subgroup effects remain uncertain. |
VITAL autoimmune disease analysis9 |
Composite outcome. Individual disease effects were not clearly proven. |
Are results consistent across studies?
The evidence is consistent for deficiency: vitamin D matters when people do not have enough.
The evidence is also consistent in another direction: giving extra vitamin D to mostly healthy, mostly vitamin-D-sufficient adults does not reliably prevent major diseases.
Results are mixed for selected-risk groups. That is why WEH rates these as plausible, not proven, rather than “supported” for everyone.
Safety note
Vitamin D can be toxic at excessive doses. Toxicity can cause high calcium levels, kidney stones, nausea, vomiting, weakness, kidney failure, soft-tissue calcification, abnormal heart rhythms, and rarely death.1
The adult tolerable upper intake level is 100 micrograms, or 4,000 IU, per day. This is the highest usual daily intake considered unlikely to cause harm for most adults, not a target dose.1
The USPSTF also notes that calcium plus vitamin D can slightly increase kidney stone risk.3
People with kidney disease, sarcoidosis or other granulomatous diseases, hyperparathyroidism, a history of kidney stones, malabsorption, osteoporosis treatment, pregnancy, or prescription vitamin D should follow clinician guidance.
Vitamin D supplements can also interact with some medicines, including orlistat, statins, corticosteroids, and thiazide diuretics.1
What this means for you
Vitamin D is worth taking when you are deficient, at high risk of deficiency, advised to take it during pregnancy, older and at risk, or taking it for a clear bone-health reason. It is not a proven shortcut for preventing most chronic diseases.
A reasonable evidence-based framing is: meet your daily vitamin D needs, correct deficiency when present, and be skeptical of high-dose “wellness” claims.
For falls and fractures in older adults, exercise, osteoporosis screening when appropriate, vision review, medication review, and home-safety changes may matter more than routine vitamin D pills for people who are not deficient.3
What we still do not know
The best target blood level for many non-bone outcomes is still uncertain. The 2024 Endocrine Society guideline says the benefit-risk ratio and optimal 25-hydroxyvitamin D concentration for disease prevention remain unclear.2
Common pathology reference ranges for 25-hydroxyvitamin D: these ranges are for the blood test used to assess vitamin D stores. They are not proof that higher levels improve non-bone outcomes.
Australia: RCPA lists a reference interval of 50–200 nmol/L, with adequacy at ≥50 nmol/L at the end of winter. Australian Clinical Labs gives the same adequate threshold and notes that 60–70 nmol/L at the end of summer allows for seasonal decline.1011
United States: major commercial pathology directories commonly list 30–100 ng/mL, which is about 75–250 nmol/L. Labcorp and Quest both publish 30–100 ng/mL for 25-hydroxyvitamin D, although interpretation should follow the range printed on the local laboratory report.1213
Future trials need to focus on people with low baseline vitamin D, clear clinical outcomes, adequate follow-up, and daily dosing patterns that reflect real-world use.
Frequently asked questions
Should I take vitamin D supplements every day? ⌄
Most healthy adults who get adequate sun exposure and eat a varied diet do not need a daily supplement. The evidence clearly supports daily vitamin D for people who are deficient, rarely outdoors, have dark skin in a low-sun climate, are pregnant, or are older than 75.2 It is not a proven shortcut for preventing cancer, heart disease, or depression in people who already have enough vitamin D.46
What does vitamin D deficiency actually cause? ⌄
Prolonged vitamin D deficiency causes rickets in children (soft, misshapen bones) and osteomalacia in adults (bone softening with pain and muscle weakness). It can also lower blood calcium levels, leading to muscle cramps and, in severe cases, tetany.1 These are serious but treatable conditions. Diagnosis is made with a blood test measuring 25-hydroxyvitamin D. Deficiency should not be confused with the much weaker evidence around vitamin D and other health outcomes in people who are already sufficient.
Does vitamin D protect against cancer? ⌄
No, not reliably. The VITAL trial — one of the largest randomized controlled trials on vitamin D, with 25,871 participants followed for a median of 5.3 years — found that vitamin D3 at 2,000 IU per day did not significantly reduce invasive cancer incidence compared with placebo.4 Some exploratory subgroup signals (for example, cancer mortality after two or more years) were reported but these were secondary analyses and require replication in dedicated trials before they can change practice.
Can you take too much vitamin D? ⌄
Yes. Vitamin D toxicity causes dangerously high blood calcium (hypercalcaemia), which can lead to kidney stones, nausea, vomiting, weakness, kidney failure, soft-tissue calcification, irregular heart rhythms, and rarely death.1 The adult tolerable upper intake level is 4,000 IU (100 micrograms) per day — this is the ceiling considered unlikely to cause harm in most adults, not a recommended dose. High-dose supplementation above this level should only be used under direct medical supervision with blood monitoring. Note also that calcium combined with vitamin D can slightly raise the risk of kidney stones.3
What is a normal vitamin D level on a blood test? ⌄
Reference ranges vary by country and laboratory. In Australia, the RCPA lists adequacy at 50 nmol/L or above at the end of winter, with a reference interval of 50–200 nmol/L.10 In the United States, major commercial laboratories typically report 30–100 ng/mL (roughly 75–250 nmol/L).1213 Always interpret your result against the reference range printed on your own laboratory report — units and thresholds differ between countries. Importantly, having a level within the reference range does not mean that taking extra supplements will improve your health outcomes beyond bone and deficiency management.
Sources
- NIH Office of Dietary Supplements. Vitamin D: Health Professional Fact Sheet. Updated 27 June 2025. Official evidence summary.
- Demay MB, et al. Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. 2024. PMID: 38828931. Clinical practice guideline.
- U.S. Preventive Services Task Force. Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Falls and Fractures in Community-Dwelling Adults. Draft recommendation, 17 December 2024. Systematic evidence review and recommendation.
- Manson JE, et al. Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease. New England Journal of Medicine. 2019;380:33-44. PMID: 30415629. DOI: 10.1056/NEJMoa1809944. Randomized controlled trial.
- LeBoff MS, et al. Supplemental Vitamin D and Incident Fractures in Midlife and Older Adults. New England Journal of Medicine. 2022;387:299-309. PMID: 35939577. DOI: 10.1056/NEJMoa2202106. Randomized controlled trial ancillary analysis.
- Okereke OI, et al. Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores. JAMA. 2020;324:471-480. PMID: 32749491. DOI: 10.1001/jama.2020.10224. Randomized controlled trial ancillary study.
- Pittas AG, et al. Vitamin D Supplementation and Prevention of Type 2 Diabetes. New England Journal of Medicine. 2019;381:520-530. PMID: 31173679. DOI: 10.1056/NEJMoa1900906. Randomized controlled trial.
- Jolliffe DA, et al. Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data. Lancet Diabetes & Endocrinology. 2025;13:307-320. PMID: 39993397. DOI: 10.1016/S2213-8587(24)00348-6. Systematic review and meta-analysis.
- Hahn J, et al. Vitamin D and marine omega 3 fatty acid supplementation and incident autoimmune disease: VITAL randomized controlled trial. BMJ. 2022;376:e066452. PMID: 35082139. DOI: 10.1136/bmj-2021-066452. Randomized controlled trial ancillary analysis.
- Royal College of Pathologists of Australasia. Vitamin D. RCPA Manual. Last reviewed 2 January 2024. Pathology reference interval and interpretation.
- Australian Clinical Labs. Managing Vitamin D Deficiency: A Clinical Guide to Diagnosis and Treatment. Pathology education article. Australian target threshold interpretation.
- Labcorp. Vitamin D, 25-Hydroxy. Test number 081950. US commercial laboratory reference range.
- Quest Diagnostics. Vitamin D, 25-Hydroxy, Total, Immunoassay. Test code 17306. US commercial laboratory reference range.
